FDA-Inspected Site

Reproductive Gynecology Laboratories

8 FDA inspections are on record for Reproductive Gynecology Laboratories in Akron, United States.

Clean· No action indicated

Akron, United States · Last updated July 10, 2026

Overview

  • 8 FDA inspections are on record.
  • 1 inspection produced a Form 483.
  • The most recent recorded inspection date is 2026-04-07.

At a glance

Inspections

8

Form 483s

1

EIRs

0

Last outcome

Clean

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
2 Apr 2026 – 7 Apr 2026BiologicsClean
6 Jan 2023 – 10 Jan 2023BiologicsClean
6 Nov 2019 – 7 Nov 2019BiologicsClean
27 Nov 2017 – 28 Nov 2017BiologicsClean
12 Nov 2014 – 13 Nov 2014BiologicsClean
15 Jan 2013Not recorded483View 483 →
1 Mar 2011Not recordedClean
10 Jul 2007Not recordedClean

Observations on record

Form 483 observations cited at this site, most recent first.

15 Jan 2013
21 CFR 1271.47(a)

Testing, screening, donor eligibility procedures

Cited by Nancy L Neiger

15 Jan 2013
21 CFR 1271.55(d)(2)

Accurate, indelible, legible

Cited by Nancy L Neiger

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 1271.47(a)Cited across public-safe Form 483 observations1x
21 CFR 1271.55(d)(2)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Reproductive Gynecology Laboratories' 1 Form 483

Verbatim observations and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat